PROTECT MULTI AKTIENANLEIHE - BASF/MERCK/BAYER Share Price

Certificat

DE000VM5FQR6

Delayed Deutsche Boerse AG 05:35:14 21/05/2024 pm IST
99.96 EUR -0.04% Intraday chart for PROTECT MULTI AKTIENANLEIHE - BASF/MERCK/BAYER
Current month+2.20%
1 month+4.78%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
21/24/21 99.96 -0.04%
20/24/20 100 +0.69%
17/24/17 99.31 -0.32%
16/24/16 99.63 -0.57%
15/24/15 100.2 +0.07%

Delayed Quote Deutsche Boerse AG

Last update May 21, 2024 at 05:35 pm IST

More quotes

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer Vontobel Vontobel
WKN VM5FQR
ISINDE000VM5FQR6
Date issued 04/12/2023
Strike 162
Maturity 20/12/2024 (213 Days)
Parity 0.16 : 1
Emission price 100
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 100.7
Lowest since issue 94.61
Spread 5
Spread %0.50%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
166.6 EUR
Average target price
182.3 EUR
Spread / Average Target
+9.46%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW